Clinical Trial Update: Cardioprotective and Metabolic Effects of Metformin in Patients With Heart Failure and Diabetes [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 trial evaluating metformin for cardioprotective and metabolic effects in patients with chronic heart failure and diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Insulin Resistance
• Type 2 Diabetes Mellitus

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Institute for Clinical and Experimental Medicine | Conditions: Insulin Resistance, Chronic Heart Failure | Phase 2, Phase 3 | Status: COMPLETED